Viewing Study NCT00685061


Ignite Creation Date: 2025-12-24 @ 12:12 PM
Ignite Modification Date: 2025-12-27 @ 9:09 PM
Study NCT ID: NCT00685061
Status: COMPLETED
Last Update Posted: 2023-10-18
First Post: 2008-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation
Sponsor: University of Miami
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module